Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease.

ABSTRACT:

SUBMITTER: Lee M 

PROVIDER: S-EPMC11452733 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature